tbuckley/cabot-search huggingface dataset:
Postablative 131I SPECT/CT Is Much More Sensitive Than Cervical Ultrasonography for the Detection of Thyroid Remnants in Patients After Total Thyroidectomy for Differentiated Thyroid Cancer
Authors: Iwona Bulzacka, Jacek Makarewicz
Journal: Clinical Nuclear Medicine (2020)

Purpose Evaluation of utility of cervical ultrasound (US) for detection of thyroid remnants (ThR) in patients after thyroidectomy for differentiated thyroid cancer. Methods Included were 154 consecutive patients (17–89 years, 123 female and 31 male patients), without known cancer residues or cervical lymph nodes metastases, admitted for ThR ablation with 131 I, 14 to 20 weeks after surgery. Neck uptake of 131 I (Tup) and thyroglobulin were determined, and location and volume of ThR detected by cervical US were recorded. On days 3 to 4 after ablation (1.7–4.6GBq, 46–124.3 mCi 131 I), neck SPECT/CT was performed, and 131 I uptake foci were assigned to one of the regions as described below. The anterior neck was divided into 2 compartments: superior and inferior to lower margin of thyroid cartilage, and each compartment was subdivided into middle and lateral regions (in SPECT/CT, posterolateral and anterolateral regions were also marked out). 131 I uptake sites and ThR detected by US, if congruent with SPECT/CT, were counted and analyzed. Results In total, 341 131 I uptake foci were found in 150 patients (97.4%) by SPECT/CT and 213 corresponding ThR in 118 patients (76.6%) by US. Ultrasound detected 30% to 46% of 131 I uptake foci in superior lateral regions, 49% in pyramidal lobe/thyroglossal duct area (both P &lt; 0.05), 74% to 77% in inferior lateral regions, and 22% in isthmus (both P &gt; 0.05). Correlation between ThR volume and Tup was strong ( r = 0.79), and that between ThR volume and thyroglobulin was weak ( r = 0.24). Conclusions Ultrasound is less sensitive than 131 I posttherapy scans for ThR detection in patients after thyroidectomy, especially for remnants located above the lower margin of thyroid cartilage.
712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial
Authors: J. Courcier, C. Dalban, B. Laguerre, S. Ladoire, P. Barthélémy, S. Oudard, F. Joly, G. Gravis Mescam, C.M. Chevreau, L. Geoffrois, E. Deluche, F. Rolland, D. Topart, S. Culine, S. Négrier, H. Mahammedi, F. Tantot, B. Escudier, R. Flippot, L. Albiges
Journal: Annals of Oncology (2020)
1497TiP REACTION – a phase Ib pilot study of nivolumab or nivolumab in combination with relatlimab after targeted radiation in patients with advanced esophagogastric cancer
Authors: V.K. Lam, R. Hales, J.L. Feliciano, K.R. Voong, E. Shin, K. Smith, V. Anagnostou, V. Velculescu, E. Thompson, C. Sears, D. Pardoll, H. Rodavia, H. Schneider, C. Hu, A. Amjad, P. Guerrieri, B.A. Jobe, A.H. Zaidi, R.J. Kelly
Journal: Annals of Oncology (2020)
A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks
Authors: Evandro F. Fang, Chenglong Xie, Joseph A. Schenkel, Chenkai Wu, Qian Long, Honghua Cui, Yahyah Aman, Johannes Frank, Jing Liao, Huachun Zou, Ninie Y. Wang, Jing Wu, Xiaoting Liu, Tao Li, Yuan Fang, Zhangming Niu, Guang Yang, Jiangshui Hong, Qian Wang, Guobing Chen, Jun Li, Hou-Zao Chen, Lin Kang, Huanxing Su, Brian C. Gilmour, Xinqiang Zhu, Hong Jiang, Na He, Jun Tao, Sean Xiao Leng, Tanjun Tong, Jean Woo
Journal: Ageing Research Reviews (2020)
Expressing Results From a Mendelian Randomization Analysis
Authors: Stephen Burgess, Christopher J. O’Donnell, Dipender Gill
Journal: JAMA Cardiology (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Cardiology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Cardiology journal
460P Update analysis of phase II study of oxaliplatin based regimen in relapsed colorectal cancer patients treated with oxaliplatin based adjuvant chemotherapy: INSPIRE study
Authors: H. Satake, M. Kotaka, K. Ishibashi, Y. Tsuji, M. Kataoka, M. Nakamura, N. Nagata, J. Sakamoto, K. Oba, H. Mishima
Journal: Annals of Oncology (2020)
768P Prognostic score combining systemic inflammation index (SII) and PD-L1 +/- LDH in advanced urinary tract carcinoma patients treated with atezolizumab: Subanalysis in the Italian population of the SAUL study
Authors: S.E. Rebuzzi, C.N. Sternberg, G. Fornarini, F. Calabro', C. Baldessari, G. Scandurra, U. De Giorgi, C. Masini, E. Naglieri, C. Caserta, L. Galli, M. Maruzzo, I. Zampiva, C. Buttigliero, C. Astolfi, G.L. Banna
Journal: Annals of Oncology (2020)
1810O Impact of malnutrition according to the GLIM criteria in cancer patients admitted to hospital
Authors: M. Nunez Abad, J. Garrido Gallego, V. Iranzo, C. Caballero Diaz, A. Fernandez Diaz, I. Shaheen, M. Meri Abad, M. Franco La Rosa, C. Garcia Gonzalez, V. Ruiz Cordero, L. Sanz Monge, A. Jimenez Portilla, A. Artero Fullana, N. Prieto Colodrero, B. Voltas Arribas, Y. Ruiz Berjaga, M. Llamas Montero, C. Sanchez Juan, C.J.C. Camps Herrero, B.T. Muresan
Journal: Annals of Oncology (2020)
548P Molecular pre-screening using comprehensive gene panels offered by clinical trials (CT)
Authors: I. Victoria Ruiz, D. Moreno, P. Sole, B. Mellado Gonzalez, E. Pineda, L. Gaba, T. Sauri, L. Ferrer Mileo, M. Orrillo, J. Maurel, H. Oliveres, M. Munoz-Mateu, M.J. Vidal Losada, O. Martinez Saez, N. Chic, N. Baste, N. Vinolas Segarra, R. Reyes, A. Prat, J. Garcia-Corbacho
Journal: Annals of Oncology (2020)
1200P Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC
Authors: K.D. Joode, H.J.M. Groen, A.A.M. Van der Veldt, K.P.M. Suijkerbuijk, J.W.B. de Groot, R. de Wijn, D.P. Hurkmans, D.M.A. van den Heuvel, K. Schmidt, J.P. Groten, E.M.E. Verdegaal, S.H. van der Burg, M.M. van den Heuvel, J.G.J.V. Aerts, E. Kapiteijn, R.H. Mathijssen
Journal: Annals of Oncology (2020)
Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes
Authors: Simona Ghetti, Nathan Kuppermann, Arleta Rewers, Sage R. Myers, Jeff E. Schunk, Michael J. Stoner, Aris Garro, Kimberly S. Quayle, Kathleen M. Brown, Jennifer L. Trainor, Leah Tzimenatos, Andrew D. DePiero, Julie K. McManemy, Lise E. Nigrovic, Maria Y. Kwok, Clinton S. Perry, Cody S. Olsen, T. Charles Casper, Nicole S. Glaser
Journal: Diabetes Care (2020)

OBJECTIVE This study assessed whether a single diabetic ketoacidosis (DKA) episode is associated with cognitive declines in children with newly diagnosed type 1 diabetes and whether the same is true in children who had previously been diagnosed after accounting for variations in glycemic control and other relevant factors. RESEARCH DESIGN AND METHODS We prospectively enrolled 758 children, 6–18 years old, who presented with DKA in a randomized multisite clinical trial evaluating intravenous fluid protocols for DKA treatment. DKA was moderate/severe in 430 children and mild in 328 children. A total of 392 children with DKA had new onset of type 1 diabetes, and the rest were previously diagnosed. Neurocognitive assessment occurred 2–6 months after the DKA episode. A comparison group of 376 children with type 1 diabetes, but no DKA exposure, was also enrolled. RESULTS Among all patients, moderate/severe DKA was associated with lower intelligence quotient (IQ) (β = −0.12, P &amp;lt; 0.001), item-color recall (β = −0.08, P = 0.010), and forward digit span (β = −0.06, P = 0.04). Among newly diagnosed patients, moderate/severe DKA was associated with lower item-color recall (β = −0.08, P = 0.04). Among previously diagnosed patients, repeated DKA exposure and higher HbA1c were independently associated with lower IQ (β = −0.10 and β = −0.09, respectively, P &amp;lt; 0.01) and higher HbA1c was associated with lower item-color recall (β = −0.10, P = 0.007) after hypoglycemia, diabetes duration, and socioeconomic status were accounted for. CONCLUSIONS A single DKA episode is associated with subtle memory declines soon after type 1 diabetes diagnosis. Sizable IQ declines are detectable in children with known diabetes, suggesting that DKA effects may be exacerbated in children with chronic exposure to hyperglycemia.
ONE-YEAR FOLLOW-UP OF BIOCHEMICAL AND VIROLOGICAL RESPONSE OF CLEVUDINE THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B-ASSOCIATED LIVER CIRRHOSIS
Authors: Min-Jung Kang, Hyun Joo Song, Ji Min Jung, Hye Jung Yeom, Seong-Eun Kim, Tae Hun Kim, Kwon Yoo, Il-Hwan Moon, Kyu Won Chung
Journal: Hepatology (2018)
How do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium
Authors: C. E. Onesti, H. Schroeder, A. Rorive, B. Sautois, M. Lecocq, M. Goffin, E. Gonne, A. Collinge, L. Nicolaers, O. Wera, A. Catot, C. Loly, A. Paulus, A. Sibille, L. E. Lousberg, F. Troisfontaine, J. Collignon, C. Gennigens, P. Freres, G. Jerusalem
Journal: Annals of Oncology (2020)
859P Impact of treatment modalities on quality of life for endometrial cancer patients in Norway
Authors: D. Forsse, H.M.J. Werner, G. Alræk Iversen, N. Nordskar, M.E. Engh, E. Berge Nilsen, I. Vistad, A. Rege, M. Sævik-Lode, S. Andreassen, J. Trovik, C. Krakstad
Journal: Annals of Oncology (2020)
1028P Clinical results of a pilot trial of GEN-009, a neoantigen vaccine containing immunogenic tumour specific neoantigens, in combination with PD-1 inhibitors in advanced cancers
Authors: M. Gillison, M.M. Awad, P. Twardowski, R.B. Cohen, M. Stein, A. Sukari, M. Johnson, R. Lackner, A. DeCillis, R. Hernandez, J. Price, L. Dowal, M. Shainheit, D.B. DeOliveira, M. Jain, P. Lapham, N. Singh, J.B. Flechtner, T. Davis
Journal: Annals of Oncology (2020)
The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region
Authors: Chen-Yuan Chiang, Tauhid Islam, Caihong Xu, Thilaka Chinnayah, Anna Marie Celina Garfin, Kalpeshsinh Rahevar, Mario Raviglione
Journal: European Respiratory Journal (2020)

<b>While COVID-19 has imposed great challenges to national tuberculosis programmes, it has also created opportunities to develop innovative strategies to ensure continuity of TB services and ultimately to strengthen TB care, prevention and control</b>https://bit.ly/3bHDQx0
1697P Cancer patients’ perceptions, opinions and feelings during the COVID-19 epidemic in the most affected Italian areas: Serial cross-sectional study
Authors: R. Passalacqua, G. Maglietta, M. Ratti, A. Gobbi, M. Bonomi, J. Saleri, G. Grizzi, F. Barbin, L. Bonassi, L. Buffoni, L. Cavanna, F. Gallina, E. Gervasi, C. Iridile, V. Lonati, R. Maddalena, F.A. Meriggi, S. Piloni, F. Campione, C. Caminiti
Journal: Annals of Oncology (2020)
735P Metastatic renal medullary and collecting duct carcinoma in the era of antiangiogenic and immune checkpoint inhibitors: A multicentric retrospective study
Authors: Z. Guillaume, E. Colomba-Blameble, P. Barthélémy, C. Saldana, C. Dumont, B. Laguerre, D. Maillet, C. Vicier, F. Rolland, D. Borchiellini, J. Thouvenin, L. Albiges, E. Auclin, S. Oudard, C. Thibault
Journal: Annals of Oncology (2020)
656P Divergent results between Advanced Prostate Cancer Consensus Conference (APCCC) panelist (P) and global non-panelist (NP) survey respondents
Authors: C.J. Ryan, A. Prizment, M. Oyenuga, K. Sacco, G. Carithers, A.G. Omlin, S. Gillessen
Journal: Annals of Oncology (2020)
787P Urachal (URAC) and non-urachal (NURAC) adenocarcinomas of the urinary bladder: A comparative comprehensive genomic profiling (CGP) study
Authors: G. Bratslavsky, P. Grivas, A. Necchi, O. Shapiro, J. Jacob, J. Elvin, J-A. Vergilio, D.I. Lin, E. Williams, M. Hiemenz, J. Tse, M. Lechpammer, J.K. Killian, S. Ramkissoon, E. Severson, A. Hemmerich, R. Huang, D. Duncan, N.A. Danziger, J.S. Ross
Journal: Annals of Oncology (2020)
885TiP LIO-1: A phase II study of lucitanib + nivolumab in patients (pts) with gynaecological tumours (CO-3810-101; NCT04042116; ENGOT-GYN3/AGO/LIO)
Authors: N. Concin, A. Gonzalez Martin, I. Vergote, S. Pignata, P. Harter, M.R. Patel, C.C. Gunderson, K. Wride, D. Lepley, R. Dusek, J. Go, S. Hurley, T. Cameron, E. Hamilton
Journal: Annals of Oncology (2020)
Remote Ischemic Perconditioning for the Treatment of Acute Ischemic Stroke
Authors: Wenbo Zhao, Changhong Ren, Xunming Ji
Journal: JAMA Neurology (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
972TiP Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma
Authors: K.J. Harrington, W.N. William, A. Khilnani, A.P. Algazi
Journal: Annals of Oncology (2020)
Underrepresentation of Women at Academic Medical Conferences—“Manels” Must Stop
Authors: Melina R. Kibbe, Muneera R. Kapadia
Journal: JAMA Network Open (2020)

Anuj Arora, MD; Yuvreet Kaur, BSc; Fahima Dossa, MD; Rosane Nisenbaum, PhD; Darby Little, BSc; Nancy N. Baxter, MD, PhD
1555P Real-world treatment patterns and effectiveness of liposomal irinotecan in a NAPOLI1-based regimen among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): A multi-academic center chart review
Authors: K.H. Yu, A. Hendifar, O. Alese, A. Draper, M. Abdelrahim, E. Burns, G. Khan, P. Cockrum, R. Bhak, C. Nguyen, M. DerSarkissian, M.S. Duh, N. Bahary
Journal: Annals of Oncology (2020)
Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association
Authors: Janani Rangaswami, Vivek Bhalla, Ian H. de Boer, Alexander Staruschenko, Johanna A. Sharp, Radhika Rajgopal Singh, Kevin Bryan Lo, Katherine Tuttle, Muthiah Vaduganathan, Hector Ventura, Peter A. McCullough
Journal: Circulation (2020)

Chronic kidney disease (CKD) with type 2 diabetes (T2D) is a major public health problem, resulting in significant cardiovascular and kidney adverse outcomes worldwide. Despite the widespread use of standard-of-care therapies for CKD with T2D over the past few decades, rates of progression to end-stage kidney disease remain high with no beneficial impact on its accompanying burden of cardiovascular disease. The advent of the newer classes of antihyperglycemic agents, including SGLT2 (sodium glucose cotransporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists, has changed the landscape of therapeutic options for patients with CKD with T2D, with demonstration of significant reductions in cardiovascular adverse events and progression to end-stage kidney disease. Several potential mechanisms exist through which these beneficial effects are achieved in both drug classes, which may be independent of their antihyperglycemic effects. This scientific statement summarizes the current literature on the cardiorenal protective effects with SGLT2 inhibitors and GLP-1 receptor agonists in patients with CKD and T2D. It reviews potential mechanistic pathways that may drive these benefits and summarizes the literature on adverse effects in patients with CKD and T2D at risk for or with established cardiovascular disease. Last, it provides practical guidance on a proposed collaborative care model bridging cardiologists, nephrologists, endocrinologists, and primary care physicians to facilitate the prompt and appropriate integration of these therapeutic classes in the management of patients with T2D and CKD.
Corrigendum to “pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: In vitro characteristics and in vivo biocompatibility” [biomaterials 30 (2009) 4877–4888]
Authors: Ya-Ling Chiu, Sung-Ching Chen, Chun-Jen Su, Chun-Wen Hsiao, Yu-Ming Chen, Hsin-Lung Chen, Hsing-Wen Sung
Journal: Biomaterials (2020)
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma
Authors: Maria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, Charis Bourgioti, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, Lia-Angela Moulopoulos
Journal: Blood Cancer Journal (2020)

Abstract Multiple myeloma (MM) is the second most common hematological malignancy, characterized by plasma cell bone marrow infiltration and end-organ involvement. Smoldering MM (SMM) is an intermediate clinical entity between MGUS and MM, with a risk of progression to symptomatic disease 10% per year. Bone disease is the most frequent symptom of MM, with ~90% of patients developing bone lesions throughout their disease course. Therefore, imaging plays a crucial role in diagnosis and management. Whole-body low-dose CT (WBLDCT) is widely available and has been incorporated in the latest diagnostic criteria of the IMWG. The purpose of this study was to evaluate the role of WBLDCT in the early identification of lesions in patients with SMM who progress solely with bone disease. In total, 100 asymptomatic patients were consecutively assessed with WBLDCT from July 2013 until March 2020 at baseline, 1-year after diagnosis and every 1 year thereafter. Ten percent of patients were identified as progressors with this single imaging modality. This is the first study to evaluate prospectively patients with SMM at different time points to identify early bone lesions related to MM evolution. Serial WBLDCT studies can identify early myeloma evolution and optimize disease monitoring and therapeutic strategies.
LBA44 Lenvatinib (len) plus pembrolizumab (pembro) for advanced melanoma (MEL) that progressed on a PD-1 or PD-L1 inhibitor: Initial results of LEAP-004
Authors: A.M. Arance Fernandez, S.J. O'Day, L. de la Cruz Merino, T. Petrella, R. Jamal, L. Ny, A. Carneiro, A. Berrocal, I. Márquez-Rodas, A. Spreafico, V. Victoria Atkinson, F. Costa Svedman, A.D. Smith, K. Chen, S.J. Diede, C. Krepler, G.V. Long
Journal: Annals of Oncology (2020)
Regulatory control of the Na–Cl co-transporter NCC and its therapeutic potential for hypertension
Authors: Nur Farah Meor Azlan, Maarten P. Koeners, Jinwei Zhang
Journal: Acta Pharmaceutica Sinica B (2020)

Hypertension is the largest risk factor for cardiovascular disease, the leading cause of mortality worldwide. As blood pressure regulation is influenced by multiple physiological systems, hypertension cannot be attributed to a single identifiable etiology. Three decades of research into Mendelian forms of hypertension implicated alterations in the renal tubular sodium handling, particularly the distal convoluted tubule (DCT)-native, thiazide-sensitive Na-Cl cotransporter (NCC). Altered functions of the NCC have shown to have profound effects on blood pressure regulation as illustrated by the over activation and inactivation of the NCC in Gordon's and Gitelman syndromes respectively. Substantial progress has uncovered multiple factors that affect the expression and activity of the NCC. In particular, NCC activity is controlled by phosphorylation/dephosphorylation, and NCC expression is facilitated by glycosylation and negatively regulated by ubiquitination. Studies have even found parvalbumin to be an unexpected regulator of the NCC. In recent years, there have been considerable advances in our understanding of NCC control mechanisms, particularly
591P Distress and perceived information among patients in phase I trials and their relatives: A prospective study
Authors: K.T. Gad, S.O. Dalton, P.B. Envold, A.K. Duun-Henriksen, U.N. Lassen, M. Mau-Sørensen, K.S. Rohrberg, I. Spanggaard, A. von Heymann, B.L. Høeg, C. Johansen
Journal: Annals of Oncology (2020)
170P β2-adrenergic receptor gene expression as a prognostic and predictive biomarker in HER2-positive early-stage breast cancer patients enrolled on the NCCTG-N9831 (Alliance) trial
Authors: R. Caparica, Y. Ma, C. De Angelis, F. Richard, C. Desmedt, A.H. Awada, M. Piccart, E. Perez, A. Moreno-Aspitia, S. Badve, E.A. Thompson, E. de Azambuja
Journal: Annals of Oncology (2020)
209P Safety of autologous fat grafting in breast cancer: A multicenter Italian study among 17 Senonetwork Breast Units
Authors: A. Losurdo, M. Klinger, A.V.E. Lisa, E. Morenghi, F. Corsi, C. Leonardi, S. Santicchia, A. Loreti, M.A. Bocchiotti, F. Guerini, P.C. Parodi, V. Vindigni, V. Guarneri, G. Papaccio, G. Meneghini, P. Persichetti, A. Aquinati, L. Ciuffreda, C. Tinterri, A. Santoro
Journal: Annals of Oncology (2020)
1902P Association of high-intensity statins with clinical outcome in malignant pleural mesothelioma and advanced non-small cell lung cancer patients treated with PD1 inhibitors
Authors: L. Cantini, F. Pecci, A. Lanese, D.P. Hurkmans, R.A. Belderbos, S. Aerts, R. Cornelissen, D.W. Dumoulin, C. Copparoni, I. Fiordoliva, S. Rinaldi, J.G.J.V. Aerts, R. Berardi
Journal: Annals of Oncology (2020)
VAMP2-NRG1 fusion gene is a novel oncogenic driver of non-small cell lung adenocarcinoma
Authors: Yeonjoo Jung, Seunghui Yong, Pora Kim, Hee-Young Lee, Yeonhwa Jung, Juhee Keum, Suyeon Kim, Sanghyuk Lee, Jhingook Kim, Jaesang Kim
Journal: Cancer Research (2019)
1112P Intralesional therapy with talimogene laherparepvec for stage IIIB-IVM1a melanoma is able to achieve a high rate of complete and durable responses and is associated with tumour load
Authors: E. Stahlie, V. Franke, L. Zuur, M. Klop, B.A. van de Wiel, B. van der Hiel, M. Wouters, Y. Schrage, W.J. van Houdt, A.C.J. van Akkooi
Journal: Annals of Oncology (2020)